dr. roman perez-soler on treating nsclc after first-line treatments
Published 8 years ago • 115 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:29
dr. roman perez-soler on the correlation between erlotinib-induced skin rash and overall survival
-
1:17
dr. perez-soler discusses treatment options for nsclc
-
2:56
dr. román pérez-soler discusses the use of targeted therapies in lung cancer
-
1:54
dr. perez-soler on the future of lung cancer therapies
-
4:09
the pathophysiology of non-small cell lung cancer
-
21:20
lung cancer: what you need to know
-
19:10
‘lung microwave ablation’ by prof. s diederich during the 'percutaneous interventions' session
-
0:53
dr. perez-soler on impact of osimertinib on field of nsclc
-
2:34
dr. perez-soler on the challenges oncologists face in lung cancer
-
2:09
dr. perez-soler on immunotherapy advances in sclc
-
1:58
dr. perez-soler on efficiency of ngs in lung cancer
-
1:13
dr. perez-soler on improved outlook for patients with lung cancer
-
1:42
dr. perez-soler on current status of biomarkers in sclc
-
1:30
dr. perez-soler on the utility of liquid biopsy in lung cancer
-
1:10:44
diagnosis and treatment of lung cancer
-
38:58
dr. alejandra perez
-
2:09
further: firmonertinib in nsclc with egfr pacc mutations
-
1:11
what is lung cancer?
-
1:19
lung cancer: robotic surgery and prognosis
-
6:23
iaslc 2024 world conference on lung cancer: dr. narjust florez discusses highlights
-
1:24
dr. pietanza on rova-t for small-cell lung cancer